Capecitabine in advanced hepatocellular carcinoma
Abstract
Since sorafenib was demonstrated to be active as a systemic treatment in hepatocellular carcinoma (HCC) [ 1 Llovet J.M. Ricci S. Mazzaferro V. et al. Sorafenib in advanced hepatocellular carcinoma. New England Journal of Medicine. 2008; 359: 378-390 Crossref PubMed Scopus (8967) Google Scholar , 2 Ann-Lii C. Yoon-Koo K. Zhendong C. et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular...
Paper Details
Title
Capecitabine in advanced hepatocellular carcinoma
Published Date
Oct 1, 2016
Journal
Volume
48
Issue
10
Pages
1260 - 1261
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History